Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06926530 · ClinicalTrials.gov registry record
Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Not yet
- Registry status
- 240
- Enrollment target
NCT06926530: Clinical Trial study, sponsored by Case Comprehensive Cancer Center.
NCT06926530 is a clinical trial that has not yet begun recruiting, run by Case Comprehensive Cancer Center. The registered enrollment target is 240 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06926530 has not yet begun recruiting, sponsored by Case Comprehensive Cancer Center.
- NOT YET RECRUITING
- Registry status
- 240 participants
- Enrollment target
Study Summary
This research study is enrolling participants diagnosed with breast cancer and receiving/received chemotherapy and/or endocrine therapy. The study's primary objective is to assess the differences in the use of herbs and supplements among the populations served at Cleveland Clinic Florida and Ohio by administering a participant-reported questionnaire.
Primary Outcome
Univariate analysis in which Chi-square test or Fisher's exact test will be performed.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-03 |
What is known before NCT06926530 opens enrollment
NCT06926530 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT06926530 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06926530 about?
NCT06926530 is a clinical study titled "Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations". This research study is enrolling participants diagnosed with breast cancer and receiving/received chemotherapy and/or endocrine therapy. The study's primary objective is to assess the differences in the use of herbs and supplements among the populations served at Cleveland Clinic Florida and Ohio by...
What is the current status of trial NCT06926530?
This trial is currently not yet recruiting. The enrollment target is 240 participants. The study started on 2026-06. Estimated completion is 2027-03.
What interventions are being tested in trial NCT06926530?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT06926530?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia